Trademark Filing
Urovant Sciences GmbH
Trademark Registered: 2022-09-13
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Serial Number | 79331306 |
| Registration Number | 6841623 |
| Mark Drawing Code | 2000: Illustration: Drawing or design without any word(s)/letter(s)/ number(s) |
Timeline
| 2021-08-06 | Application Filed |
| 2022-01-20 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2022-01-20 | Status: Live/Pending |
| 2022-01-22 | Transaction Date |
| 2022-09-13 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Urovant Sciences GmbH |
| Entity Statement | Gesellschaft mit beschränkter Haftung |
| Address | Viaduktstrasse 8 CH-4051 Basel CH |
| Legal Entity Type | |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 020102 | Men depicted as shadows or silhouettes of men; Silhouettes of men |
| 020701 | Groups, males |
| 241712 | Infinity symbols |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| International Codes: | 11 |
| U.S. Codes: | 013,021,023,024,031,034 |
| International Codes: | 16 |
| U.S. Codes: | 002,005,022,023,029,037,038,050 |
| International Codes: | 21 |
| U.S. Codes: | 002,013,023,029,030,033,040,050 |
| International Codes: | 25 |
| U.S. Codes: | 022,039 |
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 38 |
| U.S. Codes: | 100,101,104 |
| International Codes: | 41 |
| U.S. Codes: | 100,101,107 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations; biological preparations for medical use; pharmaceutical preparations for human use; biological and pharmaceutical preparations for medical and therapeutic use; pharmaceutical preparations for human use for the prevention of medical conditions and urological, urinary tract system and reproductive organ disorders; pharmaceutical preparations for human use for the treatment of medical conditions and urological, urinary tract system and reproductive organ disorders; biological and pharmaceutical preparations for medical and therapeutic use for the prevention of medical conditions and urological, urinary tract system and reproductive organ disorders; biological and pharmaceutical preparations for medical and therapeutic use for the treatment of medical conditions and urological, urinary tract system and reproductive organ disorders; pharmaceutical preparations for treatment of the bladder and urinary pathologies; pharmaceutical preparations for treatment of a hyperactive bladder |
| GS0411 | Providing educational information in the academic fields of education relating to prevention, identification and treatment of diseases related to medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases for the purpose of academic study; providing educational information in the academic fields of biological and pharmaceutical preparations for the prevention of medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases for the purpose of academic study; providing educational information in the fields of prevention, identification and treatment of medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases for medical purposes; educational and entertainment services, namely, services of a motivational and educational speaker in the fields of medicine, health, pharmaceuticals, and disease and disorder identification, treatment and prevention; providing online non-downloadable publications in the form of press articles in the fields of medicine, health, pharmaceuticals, and disease and disorder identification, treatment and prevention |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-01-20 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-01-22 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2022-01-26 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2022-02-11 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2022-02-18 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-02-19 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2022-03-22 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2022-03-22 | 8 RFCS P: |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-03-28 | 9 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-03-28 | 10 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-03-28 | 11 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2022-03-28 | 12 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-03-28 | 13 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-03-28 | 14 CHAN I:Incoming Correspondence |
| REFUSAL PROCESSED BY IB | 2022-04-11 | 15 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-04-26 | 16 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-04-26 | 17 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-04-27 | 18 TEME I:Incoming Correspondence |
| NEW REPRESENTATIVE AT IB RECEIVED | 2022-04-30 | 19 NREP P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2022-04-30 | 20 NREP P: |
| EXAMINERS AMENDMENT -WRITTEN | 2022-05-18 | 21 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2022-05-18 | 22 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2022-05-18 | 23 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2022-05-18 | 24 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-05-19 | 25 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2022-05-20 | 26 ALIE A:Allowance for Publication |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-06-08 | 27 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2022-06-28 | 28 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-06-28 | 29 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2022-09-13 | 30 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-09-13 | 31 NRCC E:E-Mail |
| NEW REPRESENTATIVE AT IB RECEIVED | 2022-11-25 | 32 NREP P: |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2022-12-13 | 33 FICR P: |
| FINAL DISPOSITION PROCESSED | 2022-12-15 | 34 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2022-12-15 | 35 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2023-01-09 | 36 FINO P: |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2023-03-18 | 37 ADCH M: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2024-02-23 | 38 NREP P: |
| TEAS WITHDRAWAL OF ATTORNEY RECEIVED | 2024-04-12 | 39 WOAR I:Incoming Correspondence |
| WITHDRAWAL OF ATTORNEY GRANTED | 2024-04-12 | 40 WOAG I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 